NO982854D0 - Nitrogenoksyd (NO) syntetase-inhibitor for Õ behandle eller forebygge type II diabetes - Google Patents

Nitrogenoksyd (NO) syntetase-inhibitor for Õ behandle eller forebygge type II diabetes

Info

Publication number
NO982854D0
NO982854D0 NO982854A NO982854A NO982854D0 NO 982854 D0 NO982854 D0 NO 982854D0 NO 982854 A NO982854 A NO 982854A NO 982854 A NO982854 A NO 982854A NO 982854 D0 NO982854 D0 NO 982854D0
Authority
NO
Norway
Prior art keywords
diabetes
treat
nitric oxide
synthetase inhibitor
prevent type
Prior art date
Application number
NO982854A
Other languages
English (en)
Norwegian (no)
Other versions
NO982854L (no
Inventor
Nicholas Charles Turner
Valerie Piercy
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO982854L publication Critical patent/NO982854L/no
Publication of NO982854D0 publication Critical patent/NO982854D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
NO982854A 1995-12-22 1998-06-19 Nitrogenoksyd (NO) syntetase-inhibitor for Õ behandle eller forebygge type II diabetes NO982854D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9526331.5A GB9526331D0 (en) 1995-12-22 1995-12-22 Novel method
PCT/EP1996/005871 WO1997023204A1 (en) 1995-12-22 1996-12-18 Nitric oxide (no) synthase inhibitor to treat or prevent type ii diabetes

Publications (2)

Publication Number Publication Date
NO982854L NO982854L (no) 1998-06-19
NO982854D0 true NO982854D0 (no) 1998-06-19

Family

ID=10785930

Family Applications (1)

Application Number Title Priority Date Filing Date
NO982854A NO982854D0 (no) 1995-12-22 1998-06-19 Nitrogenoksyd (NO) syntetase-inhibitor for Õ behandle eller forebygge type II diabetes

Country Status (20)

Country Link
EP (1) EP0868175B1 (cs)
JP (1) JP2000502668A (cs)
KR (1) KR19990076595A (cs)
CN (1) CN1209057A (cs)
AT (1) ATE232724T1 (cs)
AU (1) AU1379497A (cs)
BR (1) BR9612245A (cs)
CA (1) CA2240396A1 (cs)
CZ (1) CZ198698A3 (cs)
DE (1) DE69626307T2 (cs)
ES (1) ES2193285T3 (cs)
GB (1) GB9526331D0 (cs)
HU (1) HUP9903979A3 (cs)
IL (1) IL124870A0 (cs)
MX (1) MX9805098A (cs)
NO (1) NO982854D0 (cs)
NZ (1) NZ325307A (cs)
PL (1) PL327472A1 (cs)
TR (1) TR199801133T2 (cs)
WO (1) WO1997023204A1 (cs)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999044598A2 (en) * 1998-03-03 1999-09-10 Board Of Regents, The University Of Texas System Methods for inhibiting βcell apoptosis
CN1660428B (zh) * 2005-01-10 2011-09-07 王振军 一氧化氮合酶（nos）抑制剂用于治疗痔的新用途
ES2386831B1 (es) * 2011-02-04 2013-07-08 Servicio Andaluz De Salud Uso de inhibidores de la actividad de las NO sintasas (NOS) y sus composiciones, en la elaboración de un medicamento para el tratamiento y la prevención de la prediabetes y la diabetes mellitus tipo 1 (DM1)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE793646T1 (de) * 1994-11-23 1999-12-30 Pharmacia & Upjohn Co., Kalamazoo Carboxylierte aminoguanidine zum behandlung von insulin-unabhängigem diabetes mellitus

Also Published As

Publication number Publication date
NZ325307A (en) 1999-11-29
EP0868175A1 (en) 1998-10-07
JP2000502668A (ja) 2000-03-07
WO1997023204A1 (en) 1997-07-03
HUP9903979A2 (hu) 2000-03-28
ATE232724T1 (de) 2003-03-15
AU1379497A (en) 1997-07-17
GB9526331D0 (en) 1996-02-21
BR9612245A (pt) 1999-07-13
CN1209057A (zh) 1999-02-24
HUP9903979A3 (en) 2000-05-29
TR199801133T2 (xx) 1998-09-21
CA2240396A1 (en) 1997-07-03
NO982854L (no) 1998-06-19
KR19990076595A (ko) 1999-10-15
PL327472A1 (en) 1998-12-07
EP0868175B1 (en) 2003-02-19
DE69626307D1 (de) 2003-03-27
MX9805098A (es) 1998-10-31
IL124870A0 (en) 1999-01-26
ES2193285T3 (es) 2003-11-01
DE69626307T2 (de) 2003-10-16
CZ198698A3 (cs) 1999-06-16

Similar Documents

Publication Publication Date Title
NO20000786D0 (no) GABA analoger for forebyggelse og behandling av gastrointestinal skade
NO20024011L (no) Karbohydratformulering (prebiotisk hjelpemiddel) for å forbedre immunforsvaret
AP9801272A0 (en) Use of an antagonist of ppar-alpha and ppr-gamma for the treatment of syndrom X.
DK1373215T3 (da) Gelanamycinderivater egnet til behandling af cancer
AU7321598A (en) Use of cholinesterase inhibitors to treat disorders of attention
IL151628A0 (en) Combination therapies with vascular damaging activity
EP1157698A3 (en) Treatment of inflammatory diseases with oxypurine nucleosides
MX9707278A (es) Derivados tipo mercapto y seleno como inhibidores de la oxido nitrico sintasa.
NO20011757D0 (no) Reversering av viral-indusert systemisk sjokk og åndenöd ved blokkering av lymfotoksin-<beta>-veien
NO20005981L (no) Anvendelse av 2-hydroksy-4-trifluorbenzosyrederivater som inhibitorer av aktivering av den nukleære transkripsjonsfaktor NF- <kappa>B
NO982854D0 (no) Nitrogenoksyd (NO) syntetase-inhibitor for Õ behandle eller forebygge type II diabetes
WO1999057278A3 (en) IMMUNIZATION AGAINST AND TREATMENT FOR INFECTION BY $i(H.PYLORI)
NO20003813L (no) FremgangsmÕter for Õ redusere eller forhindre smerte ved bruk av spicamycin eller derivater derav
EP0974351A3 (en) Medicament for preventing and treating gastrointestinal damage
NO982853D0 (no) Aminoguanidin for behandling av NIDDM
MY118982A (en) Method of reducing tissue damage associated with ischemia
KR100348888B1 (en) Method for relieving violence and spare diet of estrous deer and method for promoting growth of antlers thereof
MY127741A (en) Wash-off vitamin e compositions
UA32146A (uk) Спосіб оцінки ефективності лікування пародонтита
EP0663211A4 (en) AGENT FOR PREVENTION AND TREATMENT OF DIGESTIVE APPARATUS MUCOUS DISORDERS.
MX9701533A (es) Procedimiento para reducir lesiones en tejidos asociadas con isquemia no cardiaca.
WO2002076405A3 (en) Compositions and methods of treatment of ulcerating diseases, burns, and related conditions
MX9605153A (es) Agentes farmaceuticos para el tratamiento de enfermedades inflamatorias cronicas y agudas.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application